APA (7th ed.) Citation

ME, W., JM, K., AD, B., KJ, B., RM, F., RI, F., . . . DJ, B. (1999). A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. The New England journal of medicine, 340(4), 253. https://doi.org/10.1056/NEJM199901283400401

Chicago Style (17th ed.) Citation

ME, Weinblatt, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, and Burge DJ. "A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor: Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate." The New England Journal of Medicine 340, no. 4 (1999): 253. https://doi.org/10.1056/NEJM199901283400401.

MLA (9th ed.) Citation

ME, Weinblatt, et al. "A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor: Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate." The New England Journal of Medicine, vol. 340, no. 4, 1999, p. 253, https://doi.org/10.1056/NEJM199901283400401.